See Attached
Please below information in RED before you start.
Johnson & Johnson SWOT Matrix template and questions.
In the narrative, be sure that you elaborate on each actions below!
(SO/ST/WO/WT actions) you developed, don’t just reiterate the contents of your table. In addition, the table
will largely give you actions…translate those into strategies like you did for your discussion post. Why are
you suggesting these strategies? Are these consistent with the overall strategy and alternatives that you
defined for the company in the early part of this Phase? If not and they indicate a new direction, support
why you think a change of direction is important. Are the strategies consistent with what the company
already pursues in terms of strategies? If not, what other strategies would it suggest? Are the strategies
consistent with the findings of the other matrices? Discuss the consistencies / inconsistencies.
a. List key external threats and opportunities
b. List key internal strengths and weaknesses
c. Match S & O to develop SO actions
d. Match W & O to develop WO actions
e. Match S & T to develop ST actions
f. Match W & T to develop WT actions
g. Translate the above SO/WO/ST/WT actions back to actual strategies.
|
Key Strengths |
Critical Weaknesses |
|
|
Market Opportunities |
SO Actions |
WO Actions |
|
Market Threats |
ST Actions |
WT Actions |
*******************************************************************************Please revise this assignment and apply it to the above Text, Template and data require for A Thru G.
Strategic Matrix with Implications for Johnson & Johnson
SWOT Matrix for Johnson & Johnson
|
Strengths 1. Diverse product portfolio (Pharma, MedTech, Consumer Health). 2. Strong brand equity and global reputation. 3. Advanced R&D capabilities and innovation. 4. Strong CSR and global presence. |
Weaknesses 1. Ongoing litigation and legal challenges. 2. Product recalls affecting brand trust. 3. Complex organizational structure. 4. Slow innovation cycles and R&D lags. |
|
Opportunities 1. Pharmaceutical innovation in emerging diseases. 2. Global health initiatives and partnerships. 3. Eco-friendly and sustainable product design. 4. Strategic acquisitions and market expansion. |
Threats 1. Intense competition across all segments. 2. Increasing regulatory and compliance pressures. 3. Supply chain disruptions and manufacturing risks. 4. Social media risks and shifting consumer trends. |
Strategic Implications
The market leadership of Johnson & Johnson includes its key strengths, including strong global brand, the presence of differentiated products, and commitment into innovation as a result of its on-going R&D (Pereira, 2024). All these attributes enable Johnson & Johnson to sustain and expand its competitive advantage. With the help of these advantages, J&J can actively go after innovation in other hotspots such as biologics, digital health, and targeted therapeutics. Through its CSR and international presence, it is able to establish brand loyalty, especially in underserved markets, which not only strengthens its profitability, but also builds up levels of brand credibility (David et al., 2023). Johnson & Johnson can achieve this by furthering investments in international collaborations and sustaining a strong talent pool to keep pace with the new trends of the markets, enhance the agility of operations, and enhance its role as a global health solutions leader.
Nevertheless, other weaknesses like product recall, liability, and a slow product innovation cycle are the major internal threats to its continued development (Pereira, 2024). Such difficulties may undermine the consumer confidence, reduce efficiency, and may end up causing losses. J&J has to shift its organizational structure and minimise bureaucratic inertia to lessen product development time and invest in fast-moving R&D in order to shorten scales of time (David et al., 2023). It can take action to prevent legal weaknesses by enhancing quality control measures and risk management structure to defend its brand integrity. Making internal transformation a primary goal will assist the company in avoiding problems related to the efficiency of operations and reinforce the capacity of the company to react to disruption of the industry and shifting consumer demands as fast as possible.
On the external front, the risk is mainly economic volatility, regulatory pressure, and increasing competition, particularly on the pharmaceutical and medtech market. The firm has to expand into green innovation and acquire in areas of high potential through acquisitions as a strategy to seize the opportunities (Pereira, 2024). Remaining responsive to the global health trends and adhering to sustainable business practices, J&J will be able to win over eco-friendly consumers and investor demands that are less lenient toward poor ESG performances (David et al., 2023). Also digital adoption and use of information on customer engagement will play a pivotal role in handling social media risks and their behavioral change. The ability to align these initiatives to its pipeline of innovation and CSR mission will enable J&J remain a global leader and future-proof its operations.
References
David, F. R., David, F. R., & David, M. E. (2023).
Strategic management (18th ed.). Pearson.
Johnson, K. (2025, March 13).
Johnson & Johnson Mission Statement: Vision: Core values. Business Strategy Hub.
Pereira, D. (2024, December 26).
Johnson & Johnson Swot Analysis (2025). Business Model Analyst.
